Schedule 13D ownership disclosure
OYSTER POINT PHARMA INC
Security class unavailable · CUSIP: 69242L106
Event date: 2019-11-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,561,888
- Percent of class
- 12.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-064066
- Form type
- SC 13D
- Filer
- Oyster Point Pharma, Inc.
- CIK
- CIK 1720725
- Filed
- Nov 14, 2019
- Reporting period
- Nov 04, 2019
- Description
- Schedule 13D beneficial ownership